Bioeconomy

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Dirk Kersten invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Geert-Jan Mulder invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Sander Slootweg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Martien van Osch is listed in a Managing Partner & CFO capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jon Edwards invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Nanna Lüneborg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Marco Boorsma invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jasper Bos invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Joy Faucher invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Alexander Hoffmann invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Dmitrij Hristodorov invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Wouter Joustra invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Rogier Rooswinkel invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Robbert van de Griendt is listed in a General Partner IR & Impact capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Machteld Groeneveld is listed in a Chief Legal Risk & Compliance Officer capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Wilfred Kevelam is listed in a Chief Accounting Officer capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Regina Salvat invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Thijs Verburg is listed in a Partner, Investor Relations capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Mathias Vinther invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Audrey Cacaly invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Vanessa Carle invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Morgan Haller invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Meike Logtenberg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Tim Lohoff invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Carolin Lanfer invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Gilles van Tienderen invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Melanie de Almeida invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Kanay Khakhria invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Maximilien Souvereyns invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Luuk de Vries invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Roberto Hofmann invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Joseph Iwasyk invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Sarah Neshat invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Nat Kolber invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Charlotte Koldeweij invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Vincent Loon invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Vivien Veninga invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

James Bayne is listed in a Fellow capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Alice Evans is listed in a Fellow, BioEconomy capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Sebastien Garnier is listed in a Fellow, BioEconomy capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Maja Wojtynska is listed in a Fellow capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Per Falholt is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Rory Gummerson is listed in a Operating Partner, Talent Acquisition capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Peter Høngaard Andersen is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Carlo Incerti is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John J.P. Kastelein is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Ton Logtenberg is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John McDonald is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John Montana is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Gijs van den Brink is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Sander van Deventer is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Philip Astley-Sparke invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Josh Brumm invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Matt Cooper invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Cees de Jong invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Michael Hayden invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Gökben Koca invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jonathan McNeill invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Yigal M. Pinto invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Patrick Round invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Onno van de Stolpe invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Patrick Vink invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jens Wendland invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Michael Burgess is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Simon J Clark is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John Ford is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Scott Friedman is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Frank G. Holz is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

An Michiels is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Stefan Oschmann is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Holger Reithinger is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Steen Riisgaard is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Liz Rodgers is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Floor Saris is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Feike Sijbesma is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Alice Vickers is listed in a Venture Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Laura Asbjornsen is listed in a Head of Marketing & Communications capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Silva Dezelan is listed in a Head of Impact and ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jennifer Fritzsche is listed in a Vice President Finance capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Cyril Lesser is listed in a Vice President Finance - Funds capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Arjan Oosterheert is listed in a Head of Tax capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Marc van Voorst tot Voorst is listed in a Head of Public Affairs capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Joost de Rijk is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Lior Alperovich is listed in a Marketing & Communications Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Vincent Conijn is listed in a Senior Associate, Impact & ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Bart de Jong is listed in a Finance Manager capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Baris Duvan is listed in a Senior Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Marnix Groot is listed in a Fund Controller capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Stijn Jochemsen is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Francine MacLeod invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Walter Schram is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Devan Sequeira is listed in a IT Solution Architect capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Thijs van Egmond is listed in a Legal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Pascal van Wees is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Iris Veldman is listed in a Deal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Viktorija Vodilovska is listed in a AI Specialist capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Patricia Vonk invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Maureen Wouters is listed in a Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Rachelle Young is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Danielle de Magalhães invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Naarden, Netherlands